Emcure Pharmaceuticals IPO: Listing debut hits ₹1,325 per share
Emcure Pharmaceuticals Ltd made a robust entry into the stock markets, surpassing expectations with significant listing gains at ₹1,325 per
Continue reading
Tag: HIV antiviral drugs